CR-Technologies launches CREASAFE®
CREASAFE® is the first ingredient application to use the controlled release system ‘Liposphere’ supported by CR-Technologies® clinical trials which provide evidence for increased retention and performance beyond that possible through traditional creatine supplementation. In a selection of studies scheduled for release in 2008, CR-Technologies® indicates that at last the sports industry finally has a delivery technology that can enhance nutrient uptake without the need for additional calories from carbohydrates.
"As a leader in the delivery and optimization of ingredients for the dietary supplement and food industry, we developed the Liposphere™ delivery system to maximize the bioavailability and stability of cutting-edge ingredients used by finished product manufacturers," says CR-Technologies® co-founder Dr Mark J Tallon. Liposphere™ is an enteric coating system that can be used on powdered ingredients. As an alternative to traditional capsule systems, which can limit product design flexibility, Liposphere™ gives manufacturers of finished products the ability to control the release of active ingredients without worrying about tablet and capsule size. This opens up the number of ingredients a finished product manufacturer can profit from.
Given the current issues surrounding overages to support the labeling laws (NLEA) in the US and Maximum limits in Europe, CR-Technologies® is excited about the current development work underway to meet these challenges, and is even now utilizing a selection of ingredients beyond creatine in their Liposphere™ system.
CREASAFE® is the first product release which utilizes the novel application of this delivery technology and represents the result of two years of research and development into the enhancement and optimization of creatine monohydrate - sports nutrition’s most efficacious ingredient. CR-Technologies®, a London based R&D and raw ingredient company with manufacturing facilities in Europe and North America, is currently in talks with three major multinationals positioning the release of CREASAFE® in late 2007.
Cr-Technologies, LLP., has also launched the industry’s first medically animated micro-website in support of its patent pending controlled release enteric delivery system Liposphere™ which can be viewed at www.creatine.tv.
For additional information about Liposphere™ and CREASAFE®, please contact CR-Technologies today